Figure 1.
Figure 2.
Sociodemographic, disease and treatment-related variables (N=430)_
| Characteristic | Sample of BC survivors |
|---|---|
| Age (mean±SD), range: 18-90 | 55.7±12.4 |
| Marital status, n (%) | |
| Married/partnered | 332 (77.2) |
| Single, divorced | 60 (14) |
| Widowed | 38 (8.8) |
| Education (n, %) | |
| Primary Education | 28 (6.5) |
| Secondary Education | 194 (45.1) |
| University, PhD | 208 (48.4) |
| Employment (n, %) | |
| Full-time employed | 171 (39.8) |
| Half-time employed | 86 (20.0) |
| Unemployed | 13 (3.0) |
| Retired | 146 (34.5) |
| Disabled retired | 14 (3.3) |
| Place of residence (n, %) | |
| Urban | 161 (37.4) |
| Suburban | 155 (36.0) |
| Rural | 114 (26.5) |
| Smoking status (n, %) | |
| Yes | 41 (9.5) |
| No | 313 (72.8) |
| No, but smoked in the past | 76 (17.7) |
| Cancer stage (n, %) | |
| 0-I | 90 (20.9) |
| II | 252 (58.6) |
| III | 88 (20.5) |
| Primary treatment, besides surgery (n, %) | |
| Chemotherapy only (C) | 48 (11.6) |
| Radiotherapy only (R) | 169 (39.3) |
| C and R | 163 (37.9) |
| None | 50 (11.6) |
| Time since treatment (mean±SD), | |
| range: 8-66 months | 29.9±18.2 |
| Hormonal therapy (n, %) | |
| Yes | 274 (63.7) |
| No | 156 (36.3) |
Final linear regression model predicting symptoms of anxiety and depression_
| Variable | HADS-A | HADS-D |
|---|---|---|
| Standardized beta | ||
| Age | -0.13* | |
| Marital status (ref. married) | ||
| Single, divorceda | 0.04 | 0.06 |
| Widoweda | 0.03 | |
| Education (ref. Primary) | ||
| Secondarya | -0.2 | -0.05 |
| University, PhDa | 0.05 | 0.03 |
| Employment status (ref. full-time) | ||
| Half-time | 0.04 | |
| Unemployeda | -0.05 | |
| Disabled retireda | 0.04 | 0.01 |
| Place of residence (ref. urban) | ||
| Rural” | 0.06 | 0.02 |
| Time since treatment | -0.01 | |
| Treatment type (ref. None) | ||
| Chemotherapya | 0.07 | |
| Chemotherapy and radiotherapya | 0.00 | 0.05 |
| No. of comorbidities | -0.01 | 0.06 |
| Psychological support | 0.03 | |
| EQ-5D - index, quality of life | -0.27** | -0.27** |
| FCRI, fear of cancer recurrence | 0.29** | 0.20** |
| RS-14, resilience | -0.15** | -0.36** |
| MPSS-total, social support | -0.10* | -0.14** |
| CaSUN-PES, unmet needs | 0.16** | |